Abstracts

ENGINEERING VACCINE IMMUNITY

Understanding the immunology of helper T cells, germinal centers, and the human naive B cell repertoire to enable better vaccine design Most vaccines provide protection from infection through the generation of neutralizing antibodies (nAbs). The repertoire of naive B cells is the starting material from which nAbs eventually arise. Immunization strategies are increasingly targeting precise…

ADAPTING THE IMMUNE RESPONSE TO CURE HEPATITIS B

Approximately 257 million people worldwide are chronically infected with the hepatitis B virus (HBV). About 900,000 people die from HBV-related liver failure and/or hepatocellular carcinoma each year, which makes HBV more deadly than HIV and malaria. Unfortunately, the incidence of HBV-related mortality is projected to increase further in the coming decades. The goal of curative…

HEPATITIS B VIRUS: NEW AGENTS

The goals of hepatitis B virus (HBV) treatment are to: 1) achieve sustained suppression of HBV replication, 2) decrease liver injury and 3) prevent cirrhosis, liver failure, hepatocellular carcinoma (HCC) and death.  Currently available FDA-approved therapies have been able to deliver on each of these clinical goals, using well-tolerated nucleos(t)ide analogues with high barriers to…

HIV AND MENTAL HEALTH: THE IMPACT OF THE COMORBIDITY IN RESOURCE-CONSTRAINED SETTINGS

There is a complex bi-directional relationship between HIV infection and mental health. It is well recognized worldwide that the prevalence of mental disorders including depression, anxiety disorders, and substance use disorders is higher in people living with HIV (PLHIV) compared to the general population. Reported prevalence estimates of mental and substance use disorders in PLHIV…

GLOBAL ELIMINATION OF HEPATITIS B VIRUS

Chronic hepatitis B virus (HBV) infection affects 250 million persons worldwide and is the most important cause of liver cirrhosis and cancer. In 2017, the World Health Organization outlined specific targets along the prevention and care cascade to be met if the elimination of HBV as a global health threat was to be achieved. Among…

PEPFAR DREAMS INTERVENTION AMONG ADOLESCENT GIRLS AND YOUNG WOMEN IN RAKAI, UGANDA

In 2016, the Presidents Emergency Plan for AIDS Relief (PEPFAR) initiated the DREAMS (Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe women) programs in10 sub-Saharan Africa countries including Uganda to reduce risk of HIV and domestic violence in  adolescent girls and young women aged 15-24 (AGYW). We used population-based data to evaluate the impact of  DREAMS  in Rakai, south-central Uganda We identified…